Usefulness of cell-free and concentrated pleural effusion reinfusion therapy in terminal cancer patients
Fujita Medical Journal · 2026-02 · 12 (1) · 6-11
DOI: 10.20407/fmj.2024-034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fujita Medical Journal, 2026-02. Verfasst von Hiroyuki Fujisaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Palliative Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
Patients with advanced or recurrent cancer often suffer from excessive fluid retention, which substantially affects their quality of life. There are no detailed reports regarding cell-free and concentrated pleural effusion reinfusion therapy (CPRT). Thus, we investigated the usefulness of CPRT for pleural effusions in terminal cancer patients.
Methods
We evaluated the efficacy and complications of CPRT in 29 patients treated at Fujita Health University Nanakuri Memorial Hospital between April 2016 and August 2020. Nutritional status before and after CPRT was evaluated by measuring serum albumin (Alb) and transthyretin (TTR) levels as indicators. Clinical symptoms were assessed to evaluate the following nine items: pain, general fatigue, anorexia, dyspnea, depression, nausea, insomnia, constipation, and dry mouth.
Results
CPRT was performed a total of 71 times, with a median of one session per patient. Median volume of drained pleural fluid was 800 mL, and the median volume of reinfused fluid was 120 mL. Regarding nutritional status before and after CPRT, serum Alb and TTR values did not decrease significantly and were maintained. Clinical symptoms showed a tendency toward improvement; dyspnea, depression, and insomnia improved significantly. No correlation was observed between the volume of pleural fluid drainage and the reduction of dyspnea, but there was a mild correlation with general fatigue and nausea. Conversely, constipation was mildly inversely correlated with the volume of pleural fluid drainage.
Conclusion
CPRT for pleural effusions in patients with terminal cancer was suggested to maintain nutritional status and may be useful in improving clinical symptom.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Palliative Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
- Department of Medical Technology, Clinical Examination Division, Fujita Health University Nanakuri Memorial Hospital, Tsu, Mie, Japan.
Zitieren
APA
Fujisaki, H., Usui, M., Ito, A., Murai, M., Tsuzuki, N., Futamura, A., Imai, K., & Itani, Y. (2026). Usefulness of cell-free and concentrated pleural effusion reinfusion therapy in terminal cancer patients. Fujita Medical Journal, 12(1), 6-11. https://doi.org/10.20407/fmj.2024-034
Vancouver
Fujisaki H, Usui M, Ito A, Murai M, Tsuzuki N, Futamura A, et al. Usefulness of cell-free and concentrated pleural effusion reinfusion therapy in terminal cancer patients. Fujita Medical Journal. 2026;12(1):6-11. doi:10.20407/fmj.2024-034
BibTeX
@article{Fujisaki2026,
author = {Fujisaki, Hiroyuki and Usui, Masanobu and Ito, Akihiro and Murai, Miyo and Tsuzuki, Norimasa and Futamura, Akihiko and Imai, Kazuki and Itani, Yoshinori},
title = {Usefulness of cell-free and concentrated pleural effusion reinfusion therapy in terminal cancer patients},
journal = {Fujita Medical Journal},
year = {2026},
volume = {12},
number = {1},
pages = {6--11},
doi = {10.20407/fmj.2024-034}
}
EUVIMED